Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. by Gilmore, Andrew P. & Romer, Lewis H.
Molecular Biology of the Cell
Vol. 7,1209-1224, August 1996
Inhibition of Focal Adhesion Kinase (FAK) Signaling
in Focal Adhesions Decreases Cell Motility
and Proliferation
Andrew P. Gilmore* and Lewis H. Romer*tI
Departments of *Cell Biology and Anatomy, tPediatrics, and Anesthesiology, University of North
Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
Submitted February 9, 1996; Accepted May 14, 1996
Monitoring Editor: Masatoshi Takeichi
It has been proposed that the focal adhesion kinase (FAK) mediates focal adhesion
formation through tyrosine phosphorylation during cell adhesion. We investigated the
role of FAK in focal adhesion structure and function. Loading cells with a glutathione-
S-transferase fusion protein (GST-Cterm) containing the FAK focal adhesion targeting
sequence, but not the kinase domain, decreased the association of endogenous FAK with
focal adhesions. This displacement of endogenous FAK in both BALB/c 3T3 cells and
human umbilical vein endothelial cells loaded with GST-Cterm decreased focal adhesion
phosphotyrosine content. Neither cell type, however, exhibited a reduction in focal
adhesions after GST-Cterm loading. These results indicate that FAK mediates adhesion-
associated tyrosine phosphorylation, but not the formation of focal adhesions. We then
examined the effect of inhibiting FAK function on other adhesion-dependent cell behav-
ior. Cells microinjected with GST-Cterm exhibited decreased migration. In addition, cells
injected with GST-Cterm had decreased DNA synthesis compared with control-injected
or noninjected cells. These findings suggest that FAK functions in the regulation of cell
migration and cell proliferation.
INTRODUCTION
Cell adhesion to extracellular matrix (ECM) is medi-
ated by heterodimeric transmembrane integrins
(Hynes, 1992). In many cultured cells, integrins bridge
between matrix proteins and the cytoskeleton at sites
of tight juxtaposition between the cell surface and
matrix, known as focal adhesions (Burridge et al.,
1988). These structures link integrin cytoplasmic do-
mains with filamentous actin stress fibers (Horwitz et
al., 1986; DePasquale and Izzard, 1987, 1991; Otey et
al., 1990). Cell attachment and spreading on ECM is
associated with the organization of a number of cy-
toskeletal proteins into focal adhesions. The associa-
tion of integrins with cytoskeletal proteins seems to be
important for integrin clustering in focal adhesions
during cell adhesion (Marcantonio et al., 1990; Chen et
al., 1995; Lewis and Schwartz, 1995). In some cells, the
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assembly of focal adhesions also accompanies migra-
tion (Izzard and Lochner, 1980; Nuckolls et al., 1992;
Herman, 1993). In addition, integrin-dependent adhe-
sion at focal adhesions may serve a role in the regu-
lation of cell growth and proliferation (Ingber et al.,
1990; Schwartz et al., 1990), and similar structures may
mediate cell-matrix interactions in vivo (Drenckhahn
et al., 1988).
During integrin-mediated cell adhesion, a number
of signaling events are associated with focal adhesion
formation (Burridge et al., 1992a; Juliano and Haskill,
1993; Schwartz et al., 1995). The work of many groups
has shown that several focal adhesion proteins be-
come tyrosine-phosphorylated in response to integrin-
mediated adhesion, antibody-induced integrin clus-
tering, and cell migration (Guan et al., 1991; Kornberg
et al., 1991; Burridge et al., 1992b; Lipfert et al., 1992;
Pelletier et al., 1992; Romer et al., 1994). Much evidence
has indicated that the focal adhesion kinase (FAK)
may be responsible for these tyrosine phosphorylation
events (Richardson and Parsons, 1995). FAK is a cyto-
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plasmic tyrosine kinase that is localized to focal adhe-
sions (Hanks et al., 1992; Schaller et al., 1992) via a focal
adhesion targeting (FAT) sequence at the carboxy-
terminus (Hildebrand et al., 1993). FAK binds to sev-
eral focal adhesion proteins, including paxillin (Hilde-
brand et al., 1995), talin (Chen et al., 1995), and the
cytoplasmic domains of integrins (Schaller et al., 1995).
FAK is activated during cell adhesion and cell migra-
tion (Guan and Shalloway, 1992; Lipfert et al., 1992;
Schaller et al., 1992; Romer et al., 1994). Tyrosine kinase
inhibitors have been found to block the tyrosine phos-
phorylation of FAK and other focal adhesion proteins,
while preventing focal adhesion formation and cell
motility (Burridge et al., 1992b; Romer et al., 1992;
Chrzanowska-Wodnicka and Burridge, 1994; Ridley
and Hall, 1994; Romer et al., 1994). These data all
support the concept of a role for FAK in cytoskeletal
assembly. However, other data suggest that FAK ac-
tivation may be downstream of focal adhesion and
stress fiber formation. Thus, the tyrosine phosphory-
lation of FAK can be inhibited by cytochalasin D
(Lipfert et al., 1992; Pelletier et al., 1992; Bockholt and
Burridge, 1993; Haimovich et al., 1993; Seufferlein and
Rozengurt, 1994). Furthermore, integrin cytoplasmic
domain mutants that do not target to focal adhesions
(Marcantonio et al., 1990) do not promote tyrosine
phosphorylation or colocalization of FAK (Guan et al.,
1991; Lewis and Schwartz, 1995). These same integrin
cytoplasmic domain mutants also fail to bind talin
(Chen et al., 1995). Together, these findings suggest
that the association of integrins with the cytoskeleton
is required for FAK activation by integrins.
FAK has been linked to an extensive network of
signaling proteins that interface with growth regula-
tion (for review, Clark and Brugge, 1995). These in-
clude pp6Osrc (Schaller et al., 1994; Xing et al., 1994), the
p85 subunit of PI-3 kinase (Chen and Guan, 1994;
Guinebault et al., 1995), the adaptor protein Grb-2
(Schlaepfer et al., 1994), and Csk (Sabe et al., 1994). In
addition, paxillin, which interacts with FAK (Turner
and Miller, 1994; Bellis et al., 1995; Hildebrand et al.,
1995), can interact with the guanine nucleotide ex-
change factor C3G via the adaptor protein Crk (Birge
et al., 1993; Tanaka et al., 1994; Schaller and Parsons,
1995). This evidence supports a role for FAK in down-
stream signaling after focal adhesion formation, and in
the regulation of anchorage-dependent growth behav-
ior.
To date, a direct role for FAK has yet to be estab-
lished in the following processes: the tyrosine phos-
phorylation of focal adhesion components, the
assembly of focal adhesions, and the regulation of
anchorage-dependent growth. In this paper, we have
inhibited FAK activity in focal adhesions. Microinjec-
tion or bead loading of cells with the FAT-containing
carboxy-terminus of FAK, without the kinase domain,
was used to competitively inhibit FAK entry into focal
adhesions. We report the resulting effects on focal
adhesion tyrosine phosphorylation, focal adhesion as-




Human umbilical vein endothelial cells (HUVEC) were harvested
from fresh human umbilical veins using previously described tech-
niques (Romer et al., 1994). Segments of vessels were cannulated,
gently irrigated to remove debris, and incubated with collagenase (1
mg/ml; Worthington Biochemical, Freehold, NJ) for 10 min. The
irrigant was then agitated within the vessels and collected. Har-
vested cells were plated on tissue culture plastic that had been
preincubated with 1% gelatin (Difco, Detroit, MI) in Dulbecco's PBS.
HUVEC were cultured in medium 199 with Earle's salts, supple-
mented with vitamins and amino acids (Life Technologies, Gaith-
ersburg, MD), 20% fetal calf serum, 100 ,ug/ml heparin, -100
,tg/ml endothelial cell growth factor isolated from bovine hypo-
thalamus, 50 U/ml penicillin, 50 ,tg/ml streptomycin, and 4 ,ug/ml
amphotericin B. HUVEC were used between passages 2 and 4. Cell
identity was verified by morphology and by positive testing for von
Willebrand's factor by immunofluorescence microscopy with poly-
clonal antibody obtained from Sigma Chemical (St. Louis, MO).
BALB/c 3T3 cells were passaged every 3 d and cultured in Dulbec-
co's modified Eagle's medium, supplemented with 10% fetal calf
serum, 50 U/ml penicillin, and 50 ,ug/ml streptomycin.
Tissue culture coverslips were coated with human plasma fi-
bronectin (Life Technologies; 75 jig/ml) in TBS (150 mM NaCl, 0.1%
NaN3, 50 mM Tris-HCl, pH 7.6) at 37°C for 1 h. Before plating,
coverslips were rinsed with serum-free Dulbecco's modified Eagle's
medium.
Fusion Proteins
The fusion protein GST (29 kDa) was generated from the plasmid
pGEX3x (Pharmacia, Piscataway, NJ). GST fusion protein (GST-
Cterm) (-58 kDa) includes FAK amino acids 765 through 1052. This
was generated by an in-frame insertion of the C-terminal fragment
of wild-type FAK cDNA that included the FAT (Hildebrand et al.,
1993) sequence, but not the kinase domain, into the multiple cloning
site of pGEX2TK. GST-ANE (-64 kDa) includes FAK amino acids
685 through 965 and 1012 through 1052 with a substitution of an
alanine for the glutamic acid at FAK residue 965. This deletion
mutant is thus missing a portion of the FAT sequence. FAK con-
taining this mutation did not target to focal adhesions (Hildebrand
et al., 1993). Schematics of these fusion proteins and the intact FAK
protein are displayed in Figure 1A. The FAK fusion proteins were
generous gifts from Dr. Michael Schaller (University of North Caro-
lina at Chapel Hill, Chapel Hill, NC) and Dr. Jeff Hildebrand (Uni-
versity of Washington).
Escherichia coli containing these plasmids were grown in LB me-
dium containing 100 ,ug/ml ampicillin to mid-log phase, induced to
express FAK fusion proteins with the addition of 100 ,uM isopropyl-
,B-D-thiogalactopyranoside, and allowed to grow for an additional
2 h in a shaking incubator at 37°C. Bacterial pellets were isolated by
centrifugation at 5000 x g for 10 min at 27'C, solubilized in PBS with
1% Triton X-100/0.5 mM EDTA, and lysed by sonication for 30 s in
the presence of 10 ,ug/ml aprotinin, 10 jig/ml leupeptin, and 1 mM
phenylmethylsulfonyl fluoride. Fusion proteins were purified from
bacterial lysates on glutathione agarose (Sigma) and eluted from the
agarose with 50mM Tris-HCl, pH 8.0, containing 5 mM glutathione.
For studies of focal adhesion formation, fusion proteins were
mixed with coumarin-conjugated bovine serum albumin (BSA).
BSA at 10 mg/ml in 0.1 M sodium carbonate, pH 9.0, was labeled
overnight with 7-diethylamino-3-(4'-isothiocyanatophenyl)-4-meth-
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ylcoumarin (CPI, Molecular Probes, Eugene, OR) and then dialyzed
into microinjection buffer (75 mM KCI, 10 mM potassium phosphate
buffer, pH 7.5). The coumarin-labeled BSA was added to fusion
proteins before microinjection.
SDS-PAGE
Fusion protein solutions were combined with Laemmli sample
buffer, boiled for 3 min, and electrophoresed on 10% polyacryl-
amide gels (Laemmli, 1970) containing SDS and a bisacrylamide
concentration of 0.19%. After electrophoresis, gels were stained with
Coomassie blue.
Microinjection
FAK fusion proteins were prepared for microinjection by dialysis
against microinjection buffer (see above) and concentrated to 2
mg/ml (all fusion proteins were microinjected at this concentration
except where otherwise noted). Microinjection was done using pre-
viously described techniques (Nuckolls et al., 1992). Needles were
prepared from Kwik-fil glass capillary tubes (World Precision In-
struments, Sarasota, FL) pulled on a Brown-Flaming micropipette
puller (Sutter Instrument, San Francisco, CA). Microinjection was
done using a Leitz Diavert microscope with a X32 phase-contrast
objective and a Leitz micromanipulator (Leitz, Deerfield, IL).
Bead Loading
Fusion proteins were prepared for bead loading by dialysis against
microinjection buffer (see above), or Dulbecco's PBS, and concen-
trated to 2 mg/ml (all fusion proteins were bead-loaded at this
concentration). Pluronic F-68 (Sigma) was added to all fusion pro-
tein solutions to a final concentration of 2% (wt/vol) to enhance
macromolecular transit across the plasma membrane (Clarke and
McNeil, 1992). Fusion proteins were loaded into cells using previ-
ously described techniques (McNeil and Warder, 1987). Cells ad-
herent to fibronectin-coated coverslips were washed with PBS/2%
Pluronic F-68 for 2 min. Cells were then incubated with fusion
protein solutions for 30 s and then covered with glass beads (450-
600 ,um, Sigma) for 30 s. Cells were then returned to serum-free
growth medium.
Phosphotyrosine and Focal Adhesion
Formation Assays
BALB/c 3T3 cells or HUVEC were plated on fibronectin-coated
coverslips 1 h before microinjection. Coverslips with injected cells
were then incubated with 1 mM EDTA at 27°C for -5 min under
continuous inspection with phase microscopy until most of the cells
had rounded, but not detached. Serum-free or serum-containing
growth medium (as designated in the text below) was then returned
to the cell cultures, and the cells were allowed to respread for 1 h
before preparation for immunofluorescence.
Migration Assays
Wounds were made in confluent monolayers of either HUVEC or
BALB/c 3T3 cells 12 h after plating by clearing the cells from
one-half of the coverslip with a Teflon spatula. Cells immediately
adjacent to the wound were microinjected. After 24 h, cells were
prepared for immunofluorescence microscopy. Microinjected cells
were assigned to one of the following three categories based on their
final position in the microscopic field: baseline (those remaining at
the wound edge); migrating pack (those that migrated but did not
reach the leading edge); and leading edge (cells at the forefront of
the migrating pack).
DNA Synthesis Assays
Cells were serum-starved overnight to synchronize the cell cycle
and then plated on fibronectin-coated coverslips for 1 h in serum-
free media. Cells were then microinjected, incubated for 24 h in
medium containing 100 ,uM bromodeoxyuridine (BrdU; Sigma), and
prepared for fluorescence microscopy.
Fluorescence Microscopy and Antibodies
Cells were fixed in 3.7% formaldehyde in Dulbecco's PBS for 10 min,
rinsed in (TBS), and permeabilized for 5 min in TBS containing 0.5%
Triton X-100 before staining for fluorescence microscopy. Some
coverslips were then incubated for 30 min with py2O (ICN Bio-
chemicals, Costa Mesa, CA) and anti-GST polyclonal antisera (Mo-
lecular Probes) in TBS. The coverslips were then rinsed extensively
in TBS and stained with combined fluorophore-conjugated, affinity-
purified, donkey anti-mouse and anti-rabbit IgG antibodies in TBS
(Chemicon International, Temecula, CA) for 30 min at 37°C. For
visualization of FAK, coverslips were incubated with a monoclonal
anti-FAK antibody (Transduction Laboratories, Lexington, KY;
epitope is not in the carboxy-terminus) and stained with a second
antibody as described above. Other coverslips were incubated with
polyclonal anti-talin (N681; gift of Dr. Keith Burridge, University of
North Carolina), monoclonal anti-vinculin (7F9; gift of Dr. Alexey
Belkin, University of North Carolina), or anti-paxillin (Transduction
Laboratories), along with either polyclonal anti-phosphotyrosine
(Transduction Laboratories) or monoclonal py2O, and then stained
with second antibodies as described above. For visualization of
filamentous actin, coverslips were incubated with rhoda-
mine-conjugated phalloidin (Molecular Probes) or with coumarin-
conjugated phalloidin (Sigma) for 30 min at 37°C. For visualization
of nuclear DNA, coverslips were incubated with Hoechst reagent
(Molecular Probes) after fixation and permeabilization as above. For
visualization of BrdU incorporation, coverslips were incubated with
DNAse (0.1 U/,IA; Promega, Madison, WI) for 30 min at 37°C, and
then with monoclonal anti-BrdU antibody (Sigma) for 30 min at
37'C. After the antibody incubations, the coverslips were washed in
TBS, rinsed in deionized water, and mounted with gelvatol or
mowiol. Coverslips were viewed on a Zeiss Axiophot microscope
equipped for epifluorescence. Fluorescence micrographs were taken
on T-max 400 film (Eastman Kodak, Rochester, NY).
Statistical Methods and Study Design
All findings were confirmed in both cell types. Data from migration
experiments were analyzed by using ANOVA for repeated mea-
sures. Data from focal adhesion FAK content, focal adhesion phos-
photyrosine, focal adhesion vinculin, and DNA synthesis experi-
ments were analyzed using the Pearson chi-square test.
Experiments on focal adhesion phosphotyrosine, focal adhesion
formation, and cell motility (including dose-response studies) were
carried out blind, with the identity of the microinjected proteins not
known to the investigators until after the data were analyzed.
RESULTS
GST-Cterm Localizes to Focal Adhesions and
Displaces Endogenous FAK
GST fusion proteins, including portions of the FAK
carboxy-terminus, were prepared as described above
(see MATERIALS AND METHODS). Schematics of
the proteins GST and GST-Cterm are shown in Figure
1A. The purity of representative aliquots of each fu-
sion protein is shown in the Coomassie blue-stained
gel in Figure 1B. The localization of fusion proteins
after loading and the effects on endogenous FAK were
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Figure 1. (A) Schematic representation of FAK and GST-FAK fusion proteins relative to the complete FAK sequence. Indicated are the
kinase domain (amino acids 422-676) and the FAT sequence (amino acids 853-1012). The amino acids encoded by each of the fusion proteins
are indicated. Fusion protein constructs were made as described in MATERIALS AND METHODS. (B) Expression and purification of
GST-FAK fusion proteins for microinjection and dilutions for dose-dependent experiments. Lane 1, 2 mg/ml GST; lane 2, 0.25 mg/ml
GST-Cterm + 1.75 mg/ml GST; lane 3, 1 mg/ml GST-Cterm + 1 mg/ml GST; lane 4,2 mg/ml GST-Cterm; lane 5,2 mg/ml GST-ANE. Note
that the second set of molecular mass markers and lane 5 were taken from a separate gel. (C) Bead-loaded GST-Cterm localizes to focal










Inhibition of FAK Signaling
studied by immunofluorescence (Figure 1). After in-
jection or bead loading, the cells were rounded (but
not detached) with 1 mM EDTA in PBS. Cells were
then induced to respread by addition of serum-free
medium for 1 h and prepared for immunofluores-
cence. Injected cells were identified with an anti-GST
polyclonal antibody. GST-Cterm localized to focal ad-
hesions in both BALB/c 3T3 cells and HUVEC (Figure
1C, panels A and C). GST alone did not localize to
focal adhesions. Endogenous FAK localization was
studied in cells loaded with fusion proteins using a
monoclonal antibody (mAb) that recognizes an
epitope that is not in the carboxy-terminus. This anti-
FAK mAb did not recognize the injected GST-Cterm.
Cells microinjected or bead-loaded with GST-Cterm
showed decreased endogenous FAK in focal adhe-
sions (Figure 1C, panels B and D). Cells injected or
bead-loaded with GST alone did not exhibit a change
in endogenous FAK association with focal adhesions.
The competitive exclusion of endogenous FAK from
the focal adhesions of cells loaded with GST-Cterm
was found to be statistically significant in large sam-
ples of both BALB/c 3T3 cells and HUVEC (Table 1).
Loading of GST-Ctern Results in Reduced Focal
Adhesion Phosphotyrosine
We wished to investigate the effects of preventing
endogenous FAK localization to focal adhesions dur-
ing adhesion and spreading on fibronectin. BALB/c
3T3 cells and HUVEC were plated onto fibronectin-
coated coverslips and allowed to spread for 1 h. Cells
were then bead-loaded with either GST or GST-Cterm
(Figure 1). The cells were then rounded and allowed to
respread as above, fixed, and examined by immuno-
fluorescence. Coverslips were triple-labeled with anti-
bodies against GST and phosphotyrosine, and with
coumarin-conjugated phalloidin (Figure 2). Cells
loaded with GST-Cterm were well-spread. However,
GST-Cterm loading resulted in the reduction of focal
adhesion phosphotyrosine to undetectable levels in
both BALB/c 3T3 cells (Figure 2, A and B), and HU-
VEC (Figure 2, G and H). The prevention of focal
adhesion phosphotyrosine detected by immunofluo-
rescence in cells loaded with GST-Cterm was found to
be statistically significant in large samples of both
BALB/c 3T3 cells and HUVEC (Table 1). In contrast,
(Figure 1 cont.) adhesions and prevents endogenous FAK entry
into focal adhesions. BALB/c 3T3 cells (A and B) and HUVEC (C
and D) were plated on fibronectin-coated coverslips and allowed to
spread for 1 h before bead loading with 2 mg/ml GST-Cterm. Cells
were then rounded and allowed to respread. Cells were immuno-
stained with a polyclonal anti-GST antibody to visualize bead-
loaded cells (A and C), and with an anti-FAK mAb (B and D;
epitope is not in GST-Cterm). GST-Cterm-loaded cells demon-
strated localization of the fusion protein to focal adhesions and
displacement of endogenous FAK. Bar, 20 gm.
Table 1. Fusion protein effects on FAK, phosphotyrosine (PY), and
vinculin in bead-loaded cells
Cell type Balb/c 3T3 HUVEC
Fusion protein GST-Cterm GST GST-Cterm GST
% positive FAK 10.3 (194) 97.6 (127) 6.2 (402) 96.0 (202)
p value FAK <0.0001 <0.0001 -
% positive PY 15.6 (282) 98.4 (187) 5.5 (401) 98.7 (229)
p value PY <0.0001 <0.0001 -
% + vinculin 96.8 (186) 98.8 (172) 97.5 (203) 98.0 (200)
p value vinculin 0.839 0.753
% positive = % of total loaded cells (# counted in parentheses).
p values are for differences from GST controls.
loading of GST alone had no effect on the accumula-
tion of phosphotyrosine in focal adhesions in either
cell type (Figure 2, D, E, J, and K). Neither fusion
protein altered the actin cytoskeleton in either cell
type (Figure 2, C, F, I, and L). The data shown in
Figures 1C, 2, and Table 1 indicate that microinjected
or bead-loaded GST-Cterm localized to focal adhe-
sions, prevented endogenous FAK entry into focal
adhesions, and inhibited tyrosine phosphorylation in
focal adhesions.
The effects of GST-Cterm on focal adhesion tyrosine
phosphorylation were examined in both microinjected
and bead-loaded cells under a variety of conditions.
Anti-phosphotyrosine staining was also reduced to
undetectable levels in cells that were not rounded but
were allowed to remain spread. This demonstrated
that the effect was not restricted to newly forming
focal adhesions. Decreased phosphotyrosine in focal
adhesions was also seen in cells that were injected
with GST-Cterm, rounded, and then allowed to re-
spread in the presence of serum. The injection of GST-
Cterm at lower concentrations was associated with a
concentration-dependent reduction of focal adhesion
phosphotyrosine staining. This further suggests that
FAK is important for the tyrosine phosphorylation in
focal adhesions in adherent cells.
We examined the specificity of the effect observed
with GST-Cterm by loading the fusion protein GST-
ANE, which lacks a portion of the FAT sequence (see
Figure 1A and MATERIALS AND METHODS). Cells
loaded with GST-ANE were rounded and respread on
fibronectin in serum-free medium as above. Anti-
phosphotyrosine and anti-GST staining were com-
pared in BALB/c 3T3 cells bead-loaded with GST-
Cterm or GST-ANE (Figure 3, A and B, and C and D,
respectively). Only GST-Cterm-loaded cells showed
reduced tyrosine phosphorylation in focal adhesions.
The fusion protein made from the carboxy-terminal
deletion construct GST-ANE did not localize to focal
adhesions and had no effect on anti-phosphotyrosine
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Figure 2. Effects of GST-Cterm and GST on focal adhesion phosphotyrosine. BALB/c 3T3 cells (A-F) and HUVEC (G-L) were bead-loaded
with either GST-Cterm (A-C, G-I) or GST (D-F, J-L). Cells were then rounded and allowed to respread. Cells were triple-labeled with a
polyclonal anti-GST antibody (A, D, G, and J) to visualize bead-loaded cells, anti-phosphotyrosine mAb py2O (B, E, H, and K), and
coumarin-conjugated phalloidin (C, F, I, and L). Bar, 20 ,um.
staining. This indicates that a complete FAT sequence
is required to compete with endogenous FAK.
Formation of Focal Adhesions in
GST-Cterm-injected Cells
Previous studies have demonstrated that tyrosine ki-
nase inhibitors, such as tyrphostin AG 213 and herbi-
mycin A, can prevent the formation of focal adhesions
when cells adhere and spread on ECM proteins (Burr-
idge et al., 1992b; Romer et al., 1992, 1994). To deter-
mine whether focal adhesions could form in the ab-
sence of FAK-dependent tyrosine phosphorylation,
the localization of several cytoskeletal proteins was
examined after injection, rounding, and respreading
on fibronectin-coated coverslips. GST-Cterm was coin-
jected with coumarin-labeled BSA (see MATERIALS
AND METHODS) to identify injected cells. This pro-
vided the means to examine the effects of GST-Cterm
on both tyrosine phosphorylation and focal adhesion
protein localization within the same cell.
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Figure 3. Effect of FAK deletion variant on focal adhesion phosphotyrosine. BALB/c 3T3 cells plated on fibronectin-coated coverslips were
bead-loaded with GST-Cterm (A and B) or GST-ANE (C and D). Cells were then rounded and allowed to respread. Coverslips were
double-immunostained with anti-phosphotyrosine mAb py2O (A and C) and a polyclonal anti-GST antibody (B and D) to visualize
bead-loaded cells. Bar, 20 ,um.
Cells were injected with GST-Cterm, rounded with
EDTA as above, and allowed to respread for 1 h on
fibronectin-coated coverslips. The localization of three
prominent focal adhesion proteins, vinculin, talin, and
paxillin, was determined. GST-Cterm injection did not
prevent the localization of any of these three proteins
to focal adhesions (Figure 4, A, D, and G, respective-
ly), despite the fact that phosphotyrosine staining was
undetectable in these cells by immunofluorescence
staining (Figure 4, B, E, and H). The formation of
vinculin-containing focal adhesions in cells loaded
with GST-Cterm was confirmed in large samples of
both BALB/c 3T3 cells and HUVEC (Table 1). The
effects of GST-Cterm injection on focal adhesion for-
mation were independent of the presence of serum in
the growth medium. Identical results were obtained
with cells injected during the initial stages of spread-
ing after plating on fibronectin. The localization of the
focal adhesion proteins (1 integrin and a-actinin were
also not altered by GST-Cterm loading. Although the
methods used in these studies cannot rule out low
levels of phosphotyrosine in the focal adhesion pro-
teins of GST-Cterm-injected cells, the localization of
paxillin to focal adhesions did not appear to correlate
with its tyrosine phosphorylation. Paxillin localized to
focal adhesions that had no detectable phosphoty-
rosine by immunofluorescence.
The Effects of GST-Cterm Microinjection on
Cell Migration
Previous studies have suggested a role for FAK in the
dynamic turnover of focal adhesions during cell
movement (Romer et al., 1994). We used GST-Cterm
microinjection and an in vitro wound-healing model
to examine the role of FAK in cell migration. HUVEC
or BALB/c 3T3 cells were grown to confluence on
fibronectin-coated glass coverslips. Cells were then
cleared from one-half of the coverslip with a Teflon
spatula. Cells immediately contiguous to the wound
edge were injected with GST-Cterm or with GST
alone. The progress of cell movement is illustrated in
Figure 5. Microinjected cells were assigned to one of
three categories (defined in MATERIALS AND
METHODS): baseline (BL), migrating pack (MP), or
leading edge (LE). Data from 1266 microinjected
HUVEC are shown in Figures 5 and 6 and in Table 2.
GST-injected HUVEC showed a normal distribution
between the three categories, with 53.8% of cells in the
migrating pack, 22.2% of cells remaining at the wound
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Figure 4. Effect of GST-Cterm microinjection on focal adhesion formation. BALB/c 3T3 cells plated on fibronectin were injected with
GST-Cterm and coumarin-conjugated BSA. Cells were then rounded, allowed to respread, and processed for immunofluorescence. Couma-
rin-BSA was used to identify injected cells (C, F, and I). Cells were immunostained for phosphotyrosine with polyclonal antibody (B and H)
or the mAb py2O (E), along with either anti-vinculin mAb (A), anti-talin polyclonal antibody (D), or anti-paxillin mAb (G). Bar, 20 ,im.
baseline, and 24% of cells achieving the leading edge.
In contrast, HUVEC injected with GST-Cterm demon-
strated decreased movement (Figure 5). The majority
of GST-Cterm-injected HUVEC remained at the
wound baseline (63.9%) or just entered the migrating
pack (33.3%). Microinjection with GST-Cterm simi-
larly inhibited the motility of BALB/c 3T3 cells.
HUVEC injected with GST-ANE did not exhibit a
change in motility compared with GST-injected cells.
These data indicate that GST-Cterm microinjection
and the consequent inhibition of endogenous FAK
interactions with the cytoskeleton are associated with
decreased cell motility.
The effects of lower concentrations of GST-Cterm on
HUVEC motility were measured (Figure 1B, lanes 1-4;
Figure 6; Table 2). GST-Cterm injection was associated
with a dose-dependent effect on the ability of HUVEC
to migrate in this in vitro wound-healing model. As
the concentration of GST-Cterm increased from 0.25
mg/ml to 2 mg/ml, the number of GST-Cterm-micro-
injected HUVEC at the leading edge declined (from
10.5 to 2.8%), and the number of GST-Cterm-microin-
jected HUVEC at the wound baseline increased (from
50.7 to 63.9%). The percentages of GST-Cterm-micro-
injected HUVEC at BL and LE were significantly
changed from control values by all of the studied
GST-Cterm concentrations (by ANOVA; p < 0.001).
The Effects of GST-Cterm Microinjection on
DNA Synthesis
Wound healing in in vitro models has been shown to
be the product of both cell motility and cell prolifera-
tion (Coomber and Gotlieb, 1990). The observations
that GST-Cterm injection inhibited wound healing
and motility led us to examine the effects of displacing
FAK from focal adhesions on DNA synthesis in ad-
herent cells. BALB/c 3T3 cells or HUVEC were syn-
chronized overnight by serum starvation and plated
in serum-free medium on fibronectin-coated cover-
slips the next morning. Cells on each coverslip were
then microinjected with either GST-Cterm or with GST
alone. After injection, cells were incubated in serum-
containing medium with BrdU (100 ,uM) for 24 h and
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Figure 5. Effect of GST-Cterm microinjection on cell migration. HUVEC were grown to confluence on coverslips. Cells were cleared from
one-half of the coverslip. Cells along the wound edge were injected with either GST-Cterm (A and C) or GST alone (B and D), allowed to
migrate for 24 h, and prepared for immunofluorescence. Injected cells were visualized by staining with an anti-GST polyclonal antibody (A
and B). Coverslips were stained with rhodamine-conjugated phalloidin to visualize all cells (C and D). Cells were scored for migration in
three groups: those remaining at the wound baseline (BL), those within the migrating pack (MP), and those at the leading edge of the
migrating cells (LE). Bar, 150 ,um.
then prepared for immunofluorescence microscopy.
Cells were triple-labeled after fixation using an anti-
GST antibody to identify injected cells, an anti-BrdU
antibody to identify BrdU incorporation, i.e., new
DNA synthesis (Olson et al., 1995), and Hoechst re-
agent to highlight all of the nuclei in the microscopic
field. Representative data from experiments with
HUVEC are shown in Figure 7, A-F. The majority of
GST-injected and noninjected HUVEC demonstrated
BrdU incorporation after 24 h (Figure 7, D and E). In
contrast, GST-Cterm injection was associated with a
marked decrease in the number of nuclei that stained
positively for BrdU (Figure 7, A and B). All of the
nuclei in each of these two microscopic fields are
shown by Hoechst staining in Figure 7, C and F.
BrdU incorporation data were analyzed quantita-
tively and subjected to statistical analysis as shown in
Figure 7, G and H. HUVEC microinjected with GST
alone demonstrated a BrdU incorporation rate of 59%,
compared with 52.5% for noninjected cells. Similarly,
HUVEC microinjected with GST-ANE showed no dif-
ference in BrdU incorporation when compared with
noninjected cells (p = 0.089 by Pearson chi-square
analysis). However, BrdU incorporation fell sharply in
GST-Cterm-injected HUVEC to 15.4% (Figure 7G; p <
0.0001 by Pearson chi-square analysis). DNA synthesis
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Table 2. Dose-dependent decreases in HUVEC motility
Wound Migrating Leading
baseline pack edge
Injectate (% of total injected cells ± SEM
GST 24.0 (1.7) 53.8 (0.6) 22.2 (1.2)
CT 0.25 mg/ml 50.7 (2.5) 38.8 (1.2) 10.5 (1.8)
CT 1.0 mg/ml 51.5 (2.6) 41.1 (3.3) 6.8 (1.0)
CT 2.0 mg/ml 63.9 (5.8) 33.3 (4.4) 2.8 (1.4)
was also decreased in BALB/c 3T3 cells that had been
injected with GST-Cterm (Figure 7H). GST-injected
and noninjected BALB/c 3T3 cells demonstrated BrdU
incorporation rates of 86 and 76.3%, respectively. In
GST-Cterm-injected BALB/c 3T3 cells, BrdU incorpo-
ration fell to 30% (p < 0.0001 by Pearson chi-square
analysis). These data indicate that FAK signaling in
focal adhesions serves a role in the regulation of DNA
synthesis and cell cycle progression in adherent cells.
DISCUSSION
We have examined the effects of displacing FAK from
the focal adhesions of fibroblasts and endothelial cells.
L Previous work has shown that tyrosine phosphoryla-
tion of the focal adhesion proteins FAK, paxillin, ten-
sin, and pl30cas accompany cell adhesion and the as-
sembly of focal adhesions and stress fibers (Burridge et
al., 1992b; Guan and Shalloway, 1992; Hanks et al.,
1992; Kornberg et al., 1992; Romer et al., 1992; Schaller
et al., 1992; Bockholt and Burridge, 1993; Nojima et al.,
C 1995; Petch et al., 1995; Vuori and Ruoslahti, 1995). The
inhibition of tyrosine kinase activity has been associ-
ated with decreased focal adhesion formation and de-
creased tyrosine phosphorylation of FAK and paxillin
(Burridge et al., 1992b; Romer et al., 1992, 1994). In
addition, increased FAK activity has been shown to
correlate with new focal adhesion formation in mi-
grating endothelial cells (Romer et al., 1994). These
previous data provided correlative evidence that
FAK activation might be necessary for cytoskeletal
organization during integrin-mediated cell adhe-
sion; however, the precise role of FAK in focal ad-
hesion formation and function has remained un-
clear. Indeed, FAK-independent focal adhesion
formation has been demonstrated in murine aortic
Figure 6. The effect of GST-Cterm microinjection on cell migration
is dose-dependent. HUVEC monolayers were wounded and in-
jected with various dilutions of GST-Cterm from 0.25 mg/ml
to 2 mg/ml or with GST alone. Cells were scored as outlined in
(Figure 6 cont.) MATERIALS AND METHODS and Figure 5, and
the results are represented as the percentage of cells in each of the
three regions. (A) 2 mg/ml GST; (B) 0.25 mg/ml GST-Cterm; (C) 2
mg/ml GST-Cterm. Both concentrations of GST-Cterm increased
the percentage of injected cells at the baseline and decreased the
percentage of injected cells at the leading edge, compared with
GST-injected cells. Asterisks, p < 0.001 by ANOVA.
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Figure 7. Effect of GST-Cterm or GST microinjection on DNA synthesis. HUVEC grown on coverslips were serum-starved overnight,
injected with GST-Cterm (A-C) or GST alone (D-F), and incubated for 24 h in the presence of serum and BrdU. Cells were then stained with
anti-GST polyclonal antibody (A and D), anti-BrdU mAb (B and E), and Hoechst reagent to visualize all nuclei (C and F). Bar, 40 ,um. (G)
Quantification of inhibition of DNA synthesis by GST-Cterm in HUVEC. The percentage of cells showing any nuclear staining with the
anti-BrdU mAb is shown for GST-Cterm-injected cells (CT), GST-injected cells (GST), and noninjected cells (NI). Cells were incubated with
BrdU for 24 h after injection. Data were obtained from four experiments and a total of 623 cells. Bars, SEM; asterisks, p < 0.0001 by Pearson
chi-square analysis. (H) Quantification of GST-Cterm inhibition of DNA synthesis in BALB/c 3T3 cells. The percentage of cells showing any
nuclear staining with the anti-BrdU mAb is shown for GST-Cterm-injected cells (CT), GST-injected cells (GST), and noninjected cells (NI).
Data were obtained from three experiments and a total of 228 cells. Cells were incubated with BrdU for 24 h after injection. Bars, SEM;
asterisks, p < 0.0001 by Pearson chi-square analysis.
smooth muscle cells (Wilson et al., 1995). Our data
demonstrate that displacement of FAK from focal
adhesions decreases the level of phosphotyrosine in
these structures (Figure 2). The finding that focal
adhesion formation still occurred in this system
(Figure 4) indicates that FAK-mediated tyrosine
phosphorylation of focal adhesion constituents may
not be essential for focal adhesion assembly. This
implies that FAK activation and FAK-mediated ty-
rosine phosphorylation of focal adhesion proteins
are downstream events during integrin-mediated
cell adhesion. Previously reported changes in focal
adhesion assembly after tyrosine kinase inhibitor
treatment may, therefore, have been because of ef-
fects on kinases that modulate cytoskeletal organi-
zation but do not reside in focal adhesions.
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Our observation that focal adhesion tyrosine phos-
phorylation is inhibited by preventing FAK localiza-
tion to focal adhesions (Figure 2) is in accordance with
data from a fibroblast-dominant negative model using
pp41/43FRNK overexpression. pp41 /43FRNK (FAK-re-
lated nonkinase) is a naturally occurring truncation
that consists of the carboxy-terminal noncatalytic do-
main of FAK (Schaller et al., 1993). Recent studies have
shown that pp41/43FRNK overexpression correlates
with decreased tyrosine phosphorylation of focal ad-
hesion proteins (Richardson and Parsons, 1996). How-
ever, other investigators that have disrupted the gene
encoding FAK in mice observed no reduction in focal
adhesion phosphotyrosine in fibroblasts from embry-
onic material (Ilic et al., 1995). This divergence in find-
ings in part may be because FAK is one of a family of
nonreceptor tyrosine kinases that contains at least two
recently described FAK homologues, PYK2 and CAKf
(Lev et al., 1995; Sasaki et al., 1995). PYK2 has exhibited
rapid phosphorylation in response to stimuli that
cause intracellular calcium elevation (Lev et al., 1995).
Intracellular calcium elevation has been associated
with adhesion-mediated tyrosine phosphorylation
(Pelletier et al., 1992). Although PYK2 and CAKf3 are
not normally expressed in fibroblasts, selective pres-
sure may induce FAK null cells to express these or
other FAK homologues. This compensation may be
sufficient to support the survival of cells in culture, but
insufficient to fully replace the functions of FAK in a
whole mouse, such that death occurs after embryonic
stage E8.5, as reported by Ilic et al. (1995).
Our data indicated that focal adhesions containing
vinculin, talin, and paxillin formed in the absence of
endogenous FAK association and in the setting of
significantly diminished tyrosine phosphorylation
(Figure 4). These findings agree with data from fibro-
blasts that overexpress pp41/43FRNK, exhibit de-
creased focal adhesion phosphotyrosine, and still form
focal adhesions. Furthermore, the observations of
other investigators support the concept that focal ad-
hesion formation precedes the association of FAK with
focal adhesions. Thus, the talin-binding domain of
FAK is located within the FAT region of FAK (Chen et
al., 1995). In addition, a single segment of the (31
integrin cytoplasmic domain is associated with both
integrin localization to focal adhesions and with FAK
colocalization with antibody-clustered integrins (Mar-
cantonio et al., 1990; Lewis and Schwartz, 1995). This
same region of the integrin cytoplasmic domain also
supports tyrosine phosphorylation (Guan et al., 1991;
Lewis and Schwartz, 1995). Furthermore, tyrosine
phosphorylation after integrin clustering was found to
be dependent on the integrity of the F-actin cytoskel-
eton (Miyamoto et al., 1995). This suggests that FAK
activity is downstream of the formation of focal adhe-
sions and stress fibers. Many events that trigger FAK
activation also lead to the formation of focal adhesions
and stress fibers in adherent cells. These include inte-
grin-mediated cell adhesion, neuropeptide stimula-
tion, and exposure to lysophosphatidic acid (Burridge
et al., 1992b; Guan and Shalloway, 1992; Zachary et al.,
1992; Barry and Critchley, 1994; Chrzanowska-Wod-
nicka and Burridge, 1994; Ridley and Hall, 1994).
Some of these agonists act through the small GTP-
binding protein rho (Ridley and Hall, 1992; Kumagai
et al., 1993). All of these findings are consistent with a
sequence of events in which focal adhesion assembly
precedes FAK activation.
FAK may have a role in focal adhesion remodeling
during cell motility. This was suggested by our obser-
vations that GST-Cterm-injected cells showed de-
creased migration in an in vitro wound-healing model
(Figure 5). These results concur with the finding that
fibroblasts from FAK null mutant murine embryos
showed decreased motility (Ilic et al., 1995). In previ-
ous work, we have demonstrated that migrating en-
dothelial cells in culture exhibit increased FAK ty-
rosine phosphorylation compared with stationary
cells, and that tyrosine kinase inhibitors decrease both
tyrosine phosphorylation and migration (Romer et al.,
1994). In the current work, the specific inhibition of
FAK localization to focal adhesions by loading of GST-
Cterm resulted in dose-dependent decreases in cell
motility. The mechanism by which FAK regulates cell
migration and wound healing is not clear. "Nodes" of
talin have been documented at the edges of spreading
lamellae in fibroblasts (Depasquale and Izzard, 1991).
Because FAK binds directly to talin (Chen et al., 1995),
FAK may associate with these talin-containing nodes.
Indeed, FAK is found in the "focal complexes" de-
scribed by Nobes and Hall (1995) in response to rac
stimulation. These "focal complexes" may be equiva-
lent to the talin-containing nodes at the leading edge
of spreading lamellipodia. The presence of FAK at
these sites may be needed for the propagation of a
signaling cascade at the spreading edge of motile cells.
GST-Cterm injection could displace endogenous FAK
from these sites just as it prevents FAK entry into focal
adhesions. Alternatively, FAK may affect cell migra-
tion by downstream signaling from focal adhesions.
This downstream FAK signaling may affect both cell
motility and proliferation. Both of these processes are
important parts of wound healing in vitro (Coomber
and Gotlieb, 1990), and both are affected by decreased
FAK in focal adhesions (Figures 5 and 7).
It has long been known that most types of normal
cells require attachment to ECM for normal growth,
and that this regulatory mechanism is lost in the pro-
cess of malignant transformation (Folkman and
Moscona, 1978). Guadagno et al. (1993) showed that
anchorage-dependent cells grown in suspension arrest
in the Gl phase of the cell cycle, and this was linked to
the adhesion-dependent expression of cyclin A in late
Gl. We found that the inhibition of focal adhesion
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tyrosine phosphorylation by microinjection of the car-
boxy-terminus of FAK resulted in a decrease in the
number of cells that synthesized new DNA in the 24 h
after injection. Normal amounts of serum and growth
factors were used in the culture medium for the BrdU
incorporation experiments described in this paper.
Our results suggest that FAK activation in focal adhe-
sions may be a prerequisite for normal, adherent cells
to enter the cell cycle, even in the presence of many
growth factor-related signals. Other investigators
have reported that cytoskeletal integrity is required
for cell cycle progression in the presence of growth
factors (Bohmer et al., 1996). The inhibition of FAK
function in focal adhesions in our current model may
signal that detachment has occurred and that growth
should halt.
Several downstream effectors of FAK have been
identified that suggest mechanisms whereby FAK
may signal to the nucleus and regulate cell prolifera-
tion (Clark and Brugge, 1995; Schwartz et al., 1995).
Recent data have linked integrin-mediated adhesion
and FAK phosphorylation with the Ras signal trans-
duction pathway (Kapron-Bras et al., 1993) and mito-
gen-activated protein (MAP) kinase activation (Chen
et al., 1994; Schlaepfer et al., 1994; Morino et al., 1995;
Zhu and Assoian, 1995). These findings are in concert
with our observation that the inhibition of FAK-medi-
ated focal adhesion tyrosine phosphorylation prevents
cell cycle progression (Figure 7). Our data regarding
the effects of decreased focal adhesion association of
FAK on cell proliferation are in conflict with those of
Ilic et al. (1995). These investigators found no changes
in growth behavior in FAK null fibroblasts. The dis-
crepancy between these findings and ours may be
explained by the p53 mutation that was introduced
into the FAK null cells by that group to promote the
growth of FAK null cells in culture. Indeed, the p53
mutation that they used has been shown to enhance
the proliferation and survival of cultured cells
(Tsukada et al., 1993), and, therefore, may have coun-
teracted the antiproliferative effects caused by the ab-
sence of FAK.
Data from our studies are consistent with FAK in-
volvement in signaling pathways that support the sur-
vival of adherent cells. Although the design of our
experiments has precluded a definitive apoptosis
study to date, we observed that up to 40% of cells that
were microinjected with GST-Cterm for the BrdU ex-
periments either detached or died during the 24 h after
injection. Because GST-Cterm-injected cells formed
new focal adhesions when they were allowed to re-
spread, the decrease in cell survival was probably not
because of decreased adhesion. Preliminary observa-
tions also suggest that cell survival after GST-Cterm
microinjection is greater in the presence of serum than
in serum-free conditions. It is therefore possible that
the inhibition of FAK-mediated phosphotyrosine sig-
naling within focal adhesions by GST-Cterm microin-
jection may induce apoptosis. Indeed, others have
documented an increased rate of DNA fragmentation
in cells with decreased FAK availability after down-
regulating FAK expression with antisense oligonucle-
otides or decreasing FAK availability by antibody mi-
croinjection (Xu et al., 1996; J. Hungerford and C. Otey,
personal communication).
Our findings and those of others suggest that the
biological role of FAK includes the initiation of signal-
ing pathways from focal adhesions to the nucleus that
regulate anchorage-dependent cell behavior (Richard-
son and Parsons, 1995). FAK may principally serve as
a signaling protein in focal adhesions, rather than as a
mediator of focal adhesion assembly.
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